Grants and Contributions:
Title:
Defining Notch Therapeutics’ manufacturing process.
Agreement Number:
1008560
Agreement Value:
$470,000.00
Agreement Date:
Jul 1, 2023 - Jun 30, 2024
Description:
Notch Therapeutics aims to develop a manufacturing process for producing cellular therapy products for cancer treatment that is reliable and cost-effective to allow mainstream access to these new powerful medicines. This project supports cell manufacturing scale-up to enable rapid testing of potential products in cancer model systems.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
172-2023-2024-Q2-1008560
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
719140089
Recipient Type:
For-profit organization
Recipient's Operating Name:
Notch Therapeutics (Canada) Inc
Recipient's Legal Name:
Notch Therapeutics (Canada) Inc
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171